Invus Public Equities, L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-12
10:29 am
Purchase
2025-09-3013GvTv Therapeutics Inc.
VTVT
Invus Public Equities, L.P.393,098
9.400%
45,015increase
(+12.93%)
Filing
History
2025-10-23
5:05 pm
Purchase
2025-10-1613GRani Therapeutics Holdings, Inc.
RANI
Invus Public Equities, L.P.9,825,911
9.990%
9,825,911increase
(New Position)
Filing
History
2025-10-14
5:14 pm
Purchase
2025-10-0613GDBV Technologies S.A.
DBVT
Invus Public Equities, L.P.11,538,460
7.800%
11,538,460increase
(New Position)
Filing
History
2025-10-02
5:04 pm
Purchase
2025-09-2613GTenax Therapeutics, Inc.
TENX
Invus Public Equities, L.P.427,141
9.400%
427,141increase
(New Position)
Filing
History
2025-09-22
5:22 pm
Purchase
2025-09-1913GTango Therapeutics, Inc.
TNGX
Invus Public Equities, L.P.5,883,188
5.300%
5,883,188increase
(New Position)
Filing
History
2025-09-22
3:15 pm
Purchase
2025-09-1813GRezolute, Inc.
RZLT
Invus Public Equities, L.P.4,870,000
5.400%
4,870,000increase
(New Position)
Filing
History
2025-09-08
5:43 pm
Purchase
2025-08-2913GvTv Therapeutics Inc.
VTVT
Invus Public Equities, L.P.348,083
9.990%
348,083increase
(New Position)
Filing
History
2025-07-31
2:56 pm
Purchase
2025-06-3013GBicara Therapeutics Inc. Common Stock
BCAX
Invus Public Equities, L.P.5,216,969
9.600%
2,144,142increase
(+69.78%)
Filing
History
2025-07-31
2:48 pm
Purchase
2025-06-3013GInventiva S.A.
IVA
Invus Public Equities, L.P.14,814,813
10.600%
7,407,407increase
(+100.00%)
Filing
History
2025-07-29
1:21 pm
Purchase
2025-06-3013GKalaris Therapeutics Inc
KLRS
Invus Public Equities, L.P.282,586
1.500%
282,586increase
(New Position)
Filing
History
2025-04-17
6:50 pm
Purchase
2025-03-3113GSolid Biosciences Inc.
SLDB
Invus Public Equities, L.P.7,415,905
9.600%
3,666,864increase
(+97.81%)
Filing
History
2025-04-17
4:30 pm
Purchase
2023-12-3113GNanobiotix S.A.
NBTX
Invus Public Equities, L.P.4,232,829
8.900%
4,232,829increase
(New Position)
Filing
History
2025-04-11
4:43 pm
Purchase
2022-09-0213GAbivax S.A.
ABVX
Invus Public Equities, L.P.5,403,985
8.500%
5,403,985increase
(New Position)
Filing
History
2025-03-31
5:04 pm
Purchase
2024-10-1713GInventiva S.A.
IVA
Invus Public Equities, L.P.7,407,406
7.800%
7,407,406increase
(New Position)
Filing
History
2025-02-12
4:30 pm
Purchase
2024-12-3113GSolid Biosciences Inc.
SLDB
Invus Public Equities, L.P.3,749,041
9.400%
1,000,000increase
(+36.38%)
Filing
History
2025-02-12
4:30 pm
Unchanged
2024-12-3113GVigil Neuroscience, Inc.
VIGL
Invus Public Equities, L.P.1,991,038
4.900%
0
(Unchanged)
Filing
History
2025-02-12
4:30 pm
Sale
2024-12-3113GSyros Pharmaceuticals, Inc.
SYRS
Invus Public Equities, L.P.1,063,829
3.800%
-2,587,372decrease
(-70.86%)
Filing
History
2025-02-12
4:30 pm
Sale
2024-12-3113GGossamer Bio, Inc.
GOSS
Invus Public Equities, L.P.6,258,880
2.800%
-8,072,642decrease
(-56.33%)
Filing
History
2025-02-12
4:30 pm
Sale
2024-12-3113GScholar Rock Holding Corporation
SRRK
Invus Public Equities, L.P.10,825,013
11.400%
-2,009,433decrease
(-15.66%)
Filing
History
2024-11-12
4:58 pm
Purchase
2024-09-3013GSolid Biosciences Inc.
SLDB
Invus Public Equities, L.P.2,749,041
7.100%
240,898increase
(+9.60%)
Filing
History
Goto 0, 1, Next